Success Story: EB-1A Approved in only 20 days for an Indian Endocrinologist Under Premium Processing

 

Client’s Testimonial:

"I cannot thank your team enough for all the help and guidance. This would not have been possible without you."


On February 3rd, 2026, we received another EB-1A (Alien of Extraordinary Ability) approval for an Endocrinologist in the Field of Endocrinology (Approval Notice).


General Field: Endocrinology

Position at the Time of Case Filing: Endocrinologist

Country of Origin: India

State of Residence at the Time of Filing: Minnesota

Approval Notice Date: February 3rd, 2026

Processing Time: 20 days (Premium Processing Requested)


Case Summary:  

Diabetes and obesity represent two of the most pressing metabolic health challenges facing modern medicine. Effective management requires not only understanding complex physiological systems but also integrating technological innovations with clinical practice. This EB-1A case centered on an Indian endocrinologist who has contributed to the broader understanding of metabolic disease prevention and treatment through investigations of cardiovascular physiology, glucose regulation, and long-term metabolic health outcomes. The case was approved in only 20 days without RFE under premium processing.

The expert received 4 recommendation letters. One expert described the client's impact:

"[Client]’s expertise is evident in both [Client]’s professional and educational training, and [Client]’s unique background allows [Client] to produce undoubtedly innovative work."

North America Immigration Law Group (NAILG) framed the record around a consistent research narrative that was both clinically relevant and methodologically rigorous: the client repeatedly advanced the understanding, prevention, and management of metabolic disorders through novel research contributions and the integration of precision medicine technologies.

Evidence of Field Reliance and Peer Trust

We organized the record around independent reliance and peer trust, supported by straightforward metrics:

  • Publications: 16 peer-reviewed journal articles (4 first-authored), 10 conference abstracts (2 first-authored), 6 book chapters (2 first-authored), and 1 technical report
  • Citations: 1,225 citations, with multiple publications recognized as highly cited articles in their respective years
  • Peer review: at least 20 completed reviews for scholarly journals, including service on the editorial boards
Beyond the numbers, the petition documented that the client's work was being used as a reference point by research teams from leading institutions across the United States, Europe, Asia, and Australia. This widespread adoption demonstrates that the contributions were not isolated or dependent on one collaboration network. Instead, they were being integrated into ongoing clinical research, therapeutic development, and precision medicine initiatives across the international endocrinology community.

The Result

Our law firm is honored to have assisted with this petition and looks forward to the expert's continued contributions to diabetes and obesity treatment innovation and metabolic health advancement in the United States.